MedPath

Transcranial Random Noise Stimulation (tRNS) Over Fronto-temporal Cortex Improves Verbal Fluency and Empathy in Autism Children

Not Applicable
Completed
Conditions
Autism
ASD
Interventions
Device: tRNS Fronto-temporal cortex
Device: tRNS with sham
Device: tRNS over fusiform temporal cortex
Registration Number
NCT02004236
Lead Sponsor
Spanish Foundation for Neurometrics Development
Brief Summary

Interventional, prospective, randomized, double-blind, placebo-controlled and parallel assignment study, in which patients with Autism Spectrum Disorder (ASD) are two types of intervention by transcranial random noise stimulation (tRNS), to improve verbal fluency and empathy.

Detailed Description

Interventional, prospective, randomized, double-blind, placebo-controlled and parallel assignment study, in which patients receive three types of intervention tRNS: one group received 35 sessions focused on the fronto-temporal cortex, another group received 35 sessions focused on the temporal fusiform cortex and last placebo group was operated with 35 sessions tRNS. After brain noninvasive stimulation sessions, a blind analysis of the improvement in verbal fluency and empathy in patients with autism spectrum disorder is made. For each patient included a follow up period of three months will be established.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
225
Inclusion Criteria
  • Patients between 5 and 12 years.
  • Meet DSM-IV criteria for autism spectrum disorder.
  • Patients who have been diagnosed at least 2 years before inclusion in the study.
Exclusion Criteria
  • Acute visual or hearing loss.
  • Traumatic brain injury.
  • Other neurological disorders: migraine, epilepsy, tuberous sclerosis ...
  • Trauma at birth.
  • Mental retardation.
  • Pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
tRNS Fronto-temporal cortextRNS Fronto-temporal cortexThis group receive 35 sessions of tRNS over fronto-temporal cortex
tRNS with shamtRNS with shamThis group receive 35 sessions with sham
tRNS over fusiform temporal cortextRNS over fusiform temporal cortexThis group receive 35 sessions of tRNS over fusiform temporal cortex
Primary Outcome Measures
NameTimeMethod
Verbal FluencyDuring 3 months of intensive speech therapy during tRNS sessions

Goal: Improve in verbal fluency in ASD children between 5 and 12 years. We use D-KEFS (Delis-Kaplan Executive Function System Delis Kaplan Sorting Test), Verbal Fluency Subtest - Category Condition.

Description: The verbal fluency Category test evaluates fluent productivity in the verbal domain by asking participants to generate exemplars belonging to the category animals, and subsequently, boys´ names. Participants were given 60 s to do it.

Values: Category scores were based on the average number of items generated in the two categories (animals and boys´names) during 60 s.

Time Frame: Baseline (Before treatment) and 1 day Post-treatment (after completing 3 months of intensive speech therapy during tRNS sessions)

SociabilityDuring 3 months of intensive speech therapy during tRNS sessions

Goal: Evaluate emphaty with CARS scale in autism spectrum disorder children between 5 and 12 years after tRNS sessions.

CARS (Childhood Autism Rating Scale) by Shopler \& Reichler (1971) in Spanish version EVAI (Escala de Valoración de Autismo Infantil) by Leal-Soto, F.; Aguirre, L.P. y Williams, E.E.

Description: 15 items in the scale that evaluate: Relating to people, Imitative Behavior, Emotional Response, Body Use, Object Use, Adaptation to Change, Visual Response, Listening Response, Perceptive Response, Fear or Anxiety, Verbal Communication, Non-Verbal Communication, Activity level, Level and consistency of Intellective Relations and General Impressions.

Values: The CARS scores range from 15 to 60, with lower scores indicating better outcome. It classifies the child as not autistic (below 30), moderately autistic (30-36.5) or severely autistic (above 36.5)

Secondary Outcome Measures
NameTimeMethod
Ratio Theta/Beta Before tDCSDuring 3 months of intensive speech therapy during tRNS sessions

The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.

Theta Amplitude in T5 Before tDCSDuring 3 months of intensive speech therapy during tRNS sessions

The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tRNS intervention in ASD children between 5 and 12 years old.

Ratio Theta/Beta After tDCSDuring 3 months of intensive speech therapy during tDCS sessions

The purpose of the present study was to determine if the theta/beta ratio, and theta and beta separately, correlate with behavioral parameters, and if these measures discriminate between children a with Autism Spectrum disorder (ASD) and normal gender- and age-matched controls before and after tDCS intervention in ASD children between 5 and 12 years old.

Theta Amplitude in T5 After tDCSDuring 3 months of intensive speech therapy during tRNS sessions

Evaluate QEEG (brainwave changes in frequency bandfs and amplitude) after tRNS intervention in ASD children between 5 and 12 years old

Reaction Time in ECPT Before tDCSDuring 3 months of intensive speech therapy during tRNS sessions

ERP \& Behaviour changes in ASD children after tDCS

Omission Errors Before tDCSDuring 3 months of intensive speech therapy during tRNS sessions

ERP and behaviour changes in ASD children before tDCS

Commission Errors Before tDCSDuring 3 months of intensive speech therapy during tDCS sessions

ERP and Behaviour changes in ASD children before tDCS

P3b Wave Amplitude Before tDCSDuring 3 months of intensive speech therapy during tRNS sessions

ERP and behaviour Changes in ASD children before tDCS

Reaction Time After tDCSDuring 3 months of intensive speech therapy during tDCS sessions

ERP and behaviour Changes in ASD children after tDCS

Omissions Errors After tDCSDuring 3 months of intensive speech therapy during tDCS sessions

ERP and behaviour Changes in ASD children after tDCS

Commission Errors After tDCSDuring 3 months of intensive speech therapy during tDCS sessions

ERP and behaviour Changes in ASD children after tDCS

P3b Wave Amplitude After tDCSDuring 3 months of intensive speech therapy during tDCS sessions

ERP and behaviour Changes in ASD children after tDCS

Trial Locations

Locations (2)

New Remedies Ltd

🇬🇧

Liverpool, Merseyside, United Kingdom

Moises Aguilar Domingo

🇬🇧

Liverpool, Spain, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath